FACTITIOUS HYPOGLYCEMIA DOCUMENTED BY A MODIFIED ASSAY FOR THE MEASUREMENT OF PLASMA SULFONYLUREA

被引：5

作者：

SENER, A ^{[1
]}

GILLET, C ^{[1
]}

VERHELST, J ^{[1
]}

DEBOECK, K ^{[1
]}

MAHLER, C ^{[1
]}

MALAISSE, WJ ^{[1
]}

机构：

[1] FREE UNIV BRUSSELS,ERASMUS SCH MED,EXPTL MED LAB,B-1070 BRUSSELS,BELGIUM

来源：

DIABETIC MEDICINE | 1995年 / 12卷 / 05期

关键词：

FACTITIOUS HYPOGLYCEMIA; GLIPIZIDE; MEASUREMENT OF PLASMA SULFONYLUREA CONCENTRATION;

D O I：

10.1111/j.1464-5491.1995.tb00509.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Two cases of factitious hypoglycaemia due to intentional or inadvertent intake of glipizide by non-diabetic subjects were identified through the measurement of this sulphonylurea in plasma by a modified assay procedure.

引用

页码：433 / 435

页数：3

共 9 条

[1]

Ferner RE, Neil HAW., Sulphonylureas and hypoglycaemia, Br Med J, 296, pp. 949-950, (1988)

[2]

Nelson RL., Hypoglycaemia: fact or fiction?, Mayo Clin Proc, 60, pp. 844-850, (1985)

[3]

Teale JD, Starkey BJ, Hampton SM, Robinson J., Fisher RA, Levine DF., The prevalence of factitious hypoglycemia due to sulphonylurea abuse in the UK: a preliminary report, Practical Diabetes, 6, pp. 177-178, (1989)

[4]

Sener A., Akkan AG, Malaisse WJ., Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma, Acta Diabetol, (1995)

[5]

Service FJ, Horwitz DL, Rubenstein AH, Kuzuya H., Mako ME, Reynolds C., Et al., C‐peptide suppression test for insulinoma, J Lab Clin Med, 90, pp. 180-186, (1977)

[6]

Service FJ, O'Brien PC, Kao PC, Young WF., C‐peptide suppression test: effects of gender, age, and body mass index

[7]

implications for the diagnosis of insulinoma, J Clin Endocrinol Metab, 74, pp. 204-210, (1992)

[8]

Melander A., Wahlin-Boll E., Clinical pharmacology of glipizide, Am J Med, 75, pp. 41-45, (1983)

[9]

Shenfield GM, Boutagy JS, Webb C., A screening test for detecting sulfonylureas in plasma, Therapeutic Drug Monitoring, 12, pp. 393-397, (1990)

← 1 →